Ajanta Pharma has launched its generic of Concordia Pharmaceuticals’ Kapvay (clonidine hydrochloride) extended-release tablets. The Mumbai-based company’s launch of the product follows the Food and Drug Administration approving it on Tuesday.
The drug is indicated to treat attention deficit hyperactivity disorder as a monotherapy and as adjunctive treatment to stimulants. Ajanta’s generic will be available in 0.1-mg dosage strength.
November 22, 2017